Hillstar Bio

Hillstar Bio is a precision immunology company that is advancing a portfolio of programs against autoimmune diseases. Its lead program is an antibody designed to selectively target a root cause of Cold Agglutinin Disease (CAD) and other autoimmune diseases. Compared to existing CAD treatments, Hillstar aims to improve on safety and efficacy, as well as durability of response, setting a new gold standard for the management of CAD, and other serious autoimmune conditions with a common biological origin